||This article may require copy editing for grammar, style, cohesion, tone, or spelling. (January 2015)|
Organ trade is the trade involving inner human organs (heart, liver, kidneys, etc.) for organ transplantation. As of 2011[update], about 90,000 people were reported to have been waiting for a new organ.[where?] There is a worldwide shortage of organs available for transplantation, yet commercial trade in human organs was at one point illegal in all countries except Iran. The problem of illegal organ trafficking is widespread, although data on the exact scale of the organ market is difficult to obtain. Whether or not to legalize the organ trade to combat illegal trafficking and organ shortage is a subject of much debate. On average, an individual will wait three and a half years for an organ to become available for transplant.
- 1 Legalization of organ trade
- 2 Illegal organ trade
- 3 Impact on the poor
- 4 Scholarly debate
- 5 Proposed solutions
- 6 See also
- 7 References
Legalization of organ trade
Iran has been the only nation that allows the legal buying and selling of organs. The market is contained within the country; that is, foreigners are not allowed to buy organs of Iranian citizens. In an attempt to further limit transplant tourism, organs can only be transplanted between people of the same nationality, that is to say an Iranian cannot purchase a kidney from a refugee from another country. The system is largely charity and volunteer-based, and those tasked with matching donors and patients are not paid for their work. The Iranian system has been put up as an example of an effective and safe organ trading model by proponents of legalized donation; although the system is not without its challenges and there is no short or long-term follow up on donor health.
The non-profit organization Datpa finds donors who get their pay from the Iranian government and the receiver. Charity organizations support receivers that cannot afford the pay.
An article in Clinical Journal of the American Society of Nephrology notes that the Iranian model has avoided many problems associated with organ trade. All solutions tried in other developing countries have failed to even slow down the continual growth of organ transplant queues.
All other nations had some form of legislation meant to prevent the illegal trading of organs, whether by an outright ban or through legislation that limits how and by whom donations can be made. Many countries, including Brazil, Belgium, and France, use a system of presumed consent to increase the amount of legal organs available for transplant.[not in citation given]. In the United States, federal law prohibits the sale of organs, however the government has created initiatives to encourage organ gifting and to compensate those who freely donate their organs. In 2004, the state of Wisconsin began providing tax deductions to living donors. Worldwide, the trend has been to move towards increased regulation of organ trading. This is seen in the tightening of policies after countries like China and India came under scrutiny for human rights violations related to their organ procurement process.
In legal markets of Iran the price of a kidney is $2,000 to $4,000. In the black market the price may be above $160,000, middlemen take most of the money, the operation is dangerous to both the donor and receiver, and the buyer often gets hepatitis or HIV.
Arguments on legalization
In the 1970s pharmaceuticals that prevent organ rejection were introduced. This, along with a lack of medical regulation, helped foster the organ market. Living donor procedures include kidney, liver, cornea and lung transplants. Most organ trade involves kidney or liver transplants.
Despite numerous past failures in organ trades due to lack of contractual and/or safety regulation, Robert D. Truog, Director of the Center for Bioethics of Harvard Medical School's Department of Global Health and Social Medicine addresses the lowered safety risks in transplant procedures with available modern medical technology, along with increased regulation in contracting of organ transplantation for individuals with more government interventions.
The risk due to kidney donation is very small, the same as some beauty surgeries like liposuction. A screened donor lives longer than two kidney people in the average. On legalized organ markets the position of both the donor and the receiver would be better than on black market .
There is mainly just the risk of operation. The remaining kidney will expand to fill the gap. A second kidney has almost no benefits, as the kidneys usually fail simultaneously. However, a kidney received from a living donor lasts usually years longer than a kidney from a dead donor.
In the black market, the donors may not get sufficient after-operation care.
The legal trade on blood donation in the U.S. already produces much more blood donation than the uncompensated donation in Britain. Decades ago organ trade and blood trade were opposed on grounds of quality of traded blood or organs, but according to professor Becker the screening technology is sufficiently efficient to guarantee the safety of the organs.
Organ shortage has forced to the use of organs from cadavers of old or ill people, which has led to the organs failing or containing cancers. However, waiting for a better organ can be dangerous, due to the fact that queues often involve a high risk of dying. l
Nobel Prize–winning professor Gary Becker notes that the poor are not even allowed to sell their organs after their death to benefit their families. There was a similar fear on that a voluntary army would consist of the most poor, but also that did not happen, because often the poor did not have the required education.
Impulsive unthinking donations
Professors Becker and Elias note that if impulsive or unthinking donations are feared, a written consent with a compulsory cooling-off period could be used. Also nonpaid donations suffer from the same problem.
Bioethicist Gregory Pence is worried on the fact that family, friends, or employees feel intense social pressure to donate to a patient. Some transplant centers are said to solve this problem by "inventing" a medical excuse to reluctant donors. A monetary compensation is suggested as solution to the organ shortage that causes the problems.
Previous attempts to legalize organ trade
China has no organized system of organ donations. Since the late 1980s, there have been multiple indications that executed prisoners are the main (and, more or less, only) source of organs and tissues in the Chinese transplant programs. Despite the legality of the using executed prisoners in China, there is evidence that the government attempted to downplay the scope of organ harvesting through confidentiality agreements and laws such as the Temporary Rules Concerning the Utilization of Corpses or Organs from the Corpses of Executed Prisoners. Even with this lax regulation, China still suffered a shortage of organs for transplant.
Shortly after reports of organ harvesting emerged, Party leaders announced new legislation banning use of organs without consent. The Chinese government passed legislation ending the legal sale of organs. No legislation currently prohibits the collection of organs from deceased inmates who sign agreements before execution. China introduced new legislation in order to standardize its organ collection process. This legislation includes regulations stating which hospitals can perform operations and what the legal definition of brain-death is. Foreign transplant patients are no longer accepted. Over a year later, the law (banning use of organs without consent) did not appear to have been implemented at all.
In a 2009 interview, Manfred Nowak, the United Nations Special Rapporteur on Torture said, "The Chinese government has yet to come clean and be transparent ... It remains to be seen how it could be possible that organ transplant surgeries in Chinese hospitals have risen massively since 1999, while there are never that many voluntary donors available." Nowak submitted two reports to the U.N. Human Rights Council formally requesting the Chinese regime respond to the allegations.
Before the passage of the Transplantation of Human Organs Act in 1994, India had a successful legal market in organ trading. Low cost and availability brought in business from around the globe and transformed India into one of the largest kidney transplant centers in the world. Several problems began surfacing during the period of legal organ trade in India. In some cases patients were unaware a kidney transplant procedure even took place. Other problems included patients being promised an amount much higher than what was actually paid out. Ethical issues surrounding contribution donating pushed the Indian government to pass legislation banning the sale of organs. Despite these steps, loopholes still exist in current laws that allow non-related donors to give organs if they are emotionally close to the recipient. In many cases, the donor may not be from the same country as the patient, or even speak the same language.
In Iran the practice of selling one's kidney for profit is legal. Iran currently has no wait lists for kidney transplantation. Kidney sales are legal and regulated. The Charity Association for the Support of Kidney Patients (CASKP) and the Charity Foundation for Special Diseases (CFSD) control the trade of organs with the support of the government. The organizations match donors to recipients, setting up tests to ensure compatibility. The amounts paid to the donor vary in Iran but the average figures are $1200 for kidney donation. Employment opportunities are also offered in some cases. It has been argued that the Iranian system is in some ways coercive, as over 70% of donors are considered poor by Iranian standards. There is also evidence of highly negative outcomes both in health and emotional wellbeing for Iranian donors. The first ethnographic research on Iran's system of remunerated donation was a preliminary investigation conducted in 2002 by Diane Tober, a medical anthropologist and specialist in Iran, in association with Scheper-Hughes' Organs Watch initiative.
The sale of organs was legal in the Philippines until a ban took effect in March 2008. Prior to this, the Philippines was a popular destination for transplant tourists. The Philippine Information Agency, a branch of the government, promoted "all-inclusive" kidney transplant packages that retailed for roughly $25,000. Since instating the ban on organ selling, transplants have dropped from 1,046 in 2007, to 511 in 2010. However, Professor Roger Lee Mendoza suggests that declining numbers of transplant tourists and documented organ sales do not necessarily weaken organ black markets. Instead, these often have the opposite effect of fostering brokered and compensation-based contractual systems between underground donors, brokers and buyers.
Illegal organ trade
According to the World Health Organization (WHO), illegal organ trade occurs when organs are removed from the body for the purpose of commercial transactions. The WHO justifies these actions by stating that, “Payment for...organs is likely to take unfair advantage of the poorest and most vulnerable groups, undermines altruistic donation and leads to profiteering and human trafficking.” Despite these ordinances, it was estimated that 5% of all organ recipients engaged in commercial organ transplant in 2005. Research indicates that illegal organ trade is on the rise, with a recent report by Global Financial Integrity estimating that the illegal organ trade generates profits between $600 million and $1.2 billion per year with a span over many countries, including but not limited to
- Balkan Region
- Brazil 
- Canada 
- China 
- Costa Rica 
- Eastern Europe
- Ecuador 
- Georgia 
- Haiti 
- India 
- Mexico 
- Peru 
- South Africa 
- United States of America 
- United Kingdom
Criminal networks increasingly engage in kidnapping of people, especially children and teens, who are then taken to locations with medical equipment where they are murdered and their organs harvested for the illegal organ trade.
Poverty and loopholes in legislation also contribute to the illegal trade of organs. Poverty is seen in all countries with a large black market for organs. Legislation is another contributing factor in the illegal organ trade, especially legislation with loopholes. For example, India's Transplantation of Human Organs Act (THOA) requires that an organ donor must be a relative, spouse, or an individual donating for reasons of "affection." Often, claims of "affection" are unfounded and the organ donor has no connection to the recipient. Monetary transactions for organs are illegal in India currently, but there are no laws concerning funds given to a spouse. The spousal inclusion provides a loophole for illegal trade; in some cases organ donors marry the recipient to avoid legal penalty.
The international community and national governments have been trying to find stable, ethical systems to deal with the high demand for organ transplants. In 1968, the United States implemented the Uniform Anatomical Gift Act of 1968, which gave individuals the right to donate their organs after their death. Following, the U.S. enacted the National Organ Transplant Act of 1984, which established a national online registry for organ donors and prohibited the buying or selling of organs in the U.S. The most recent efforts of the United States to combat high organ demand include the revision of the Uniform Anatomical Gift Act in 2006 and the 2007 Charlie W. Norwood Living Organ Donation Act.
Numerous other countries have passed laws aimed at ending illegal organ trade. In 1994, India passed the Transplantation of Human Organs Act, which banned both the sale of human organs and organ transplants between non-relatives. South Africa adopted the Human Tissue Act of 1983, which outlaws the transfer of tissue (including flesh), bone, organ, or bodily fluid in exchange for payment. In May 2007, China adopted the Human Transplantation Act banning organ commercialism.
Though claims of organ trafficking are hard to substantiate due to lack of evidence and reliable data, cases of illegal organ trade have been tried and prosecuted in the past. It is estimated that 42% of organs that are transplanted are from illegal human trafficking.
In 1990, The Lancet published a document on the transplant cases of 131 renal patients from three dialysis units in the United Arab Emirates and Oman
In 1993, Bombay police exposed a kidney sale and transplantation operation run by a man known as Santosh Raut. Eleven people, including Raut and two nephrologists, were arrested, but Raut managed to escape capture. Authorities believe that Raut went on to establish similar illegal kidney centers across many Indian cities. In February 2008, another kidney transplant center, run by a man called Amit Kumar, was discovered by police in Delhi and nearby Gurgaon. Due to technological advances in fingerprinting, Kumar and Raut are now believed to be the same perpetrator, who has gone by many aliases throughout years of illegal activity. In addition to the two instances mentioned above, Kumar alias Raut is facing charges for his decades of involvement in illegal organ trade, which includes over 600 kidney transplants and the involvement of at least two hospitals.
In 2007 a man in the United Kingdom became the first person convicted under the Human Tissue Act 2004 by trying to sell his kidney online for £24,000 in order to pay off his gambling debts. Levy Izhak Rosenbaum of Brooklyn was arrested in July 2009 for conspiring to arrange the sale of an Israeli citizen's kidney for $160,000 to an undercover FBI officer. According to the complaint, Rosenbaum had said that he had been involved in the illegal sale of kidneys for 10 years. Acting US Attorney Ralph Marra said "His business was to entice vulnerable people to give up a kidney for $10,000 which he would turn around and sell for $160,000". Anthropologist and organ trade expert Nancy Scheper-Hughes stated that she had informed the FBI that Rosenbaum was "a major figure" in international organ smuggling 7 years ago, and that many of Rosenbaum's donors had come from Eastern Europe. She also heard reports that Rosenbaum held donors at gunpoint to ensure they donated their organs. Rosenbaum was arrested and pled guilty to organ trafficking in 2011.
In November 2010, the South African National Direct of Public Prosecution found St. Augustine's Hospital, owned and operated by the private company Netcare Kwa-Zulu (Pty) Limited guilty of 102 counts of activity relating to illegal kidney transplant operations. Convicted along with the private company were four transplant doctors, a nephrologist, two transplant administrative coordinates, and a translator. The charges against the parent company, Netcare, and its CEO Richard Friedland were dropped in order to obtain an admission of guilt from the hospital. The private company pleaded guilty to 109 illegal kidney operations performed on Israeli, Romanian, and Brazilian citizens between June 2001 and November 2003, including five minors. These citizens received cash following their surgeries, while the private company was paid up-front for its involvement in the operation. In December 2010, Turkish national were reported to be involved in organ trafficking in Kosovo. In 2013 "an international panel of judges from the European Union Rule of Law Mission in Kosovo" convicted 5 people for illegal organ trade.
In 2014 an alleged member of the Mexican Knights Templar cartel was arrested for the kidnapping and deaths of minors. Children were found wrapped in blankets and stuffed in a refrigerated container inside a van. Various accounts have stated the individual is part of a network that kidnaps and kills minors after which their organs are removed. Other sources of income are drug trafficking, extortion, illegal mining and illegal logging.
Illegal organ trade and organ trafficking have been depicted throughout the years in the media. The 1977 fictional novel Coma by Robin Cook, made into a movie by Michael Crichton, tells of unsuspecting medical patients who are put into a coma in order for their organs to be removed. Similarly, the 1993 book The Baby Train by Jan Brunvand reveals the mythical story of a man who wakes up in his hotel room with a missing kidney the night after flirting with a woman at a bar. In addition to books and films, the stories of organ trafficking are often depicted through television, tabloid magazines, emails, and the Internet. Moreover, many of the organ trafficking tales depicted in the media report unsubstantiated claims. An example is the 1993 British/Canadian TV program "The Body Parts Business", a series of episodes investigating alleged organ and tissue trafficking in Guatemala, Honduras,Argentina, and Russia. The series made many claims about organ trafficking that later proved to be false. One such claim includes the story about Pedro Reggi, in which "The Body Parts Business" reported that his corneas had been removed without consent during his stay in a mental facility. Pedro Reggi later came forward and dispelled this claim by saying that his corneas were still intact, and he was just suffering from an acute eye infection.
Critics[who?] argue that this sensationalized view of organ trafficking, often depicted as an urban myth, delegitimizes the illegal organ trade. They call for increased scientific research for illegal organ trade, so that organ trafficking legends can be replaced by scientific fact. Silke Meyer argues, "Only then will [organ trafficking] be taken seriously by all governments affected and will the results constitute a solid ground for the field of policy-making."
The Red Market
|This section needs additional citations for verification. (October 2014)|
In 2011, Scott Carney coined the term "Red Market" to describe a broad category of economic transactions around the human body. Drawing on the concepts black markets, white markets and gray markets he suggests that commerce in body parts is separate because bodies are not commodities in a strict sense. Instead [clarify]. Straight commerce in human bodies disguises the supply chain and reduces a human life to its meat value. Carney calls for "radical transparency" in the red market supply chain in order to protect its humanness.
His book The Red Market: On the Trail of the World's Organ Brokers, Bone Thieves, Blood Farmers and Child Traffickers traces the rise, fall, and resurgence of this multibillion-dollar underground trade through history, from early medical study and modern universities to poverty-ravaged Eurasian villages and high-tech Western labs; from body snatchers and surrogate mothers to skeleton dealers and the poor who sell body parts to survive. While local and international law enforcement have cracked down on the market, advances in science have increased the demand for human tissue—ligaments, kidneys, even rented space in women's wombs—leaving little room to consider the ethical dilemmas inherent in the flesh-and-blood trade.
According to the most recent Bulletin of the World Health Organization on the state of the international organ trade, 66,000 kidney transplants, 21,000 liver transplants, and 6000 heart transplants were performed globally in 2005. Another article reports that in 2008 the median waiting time for the U.S. transplant list was greater than 3 years (with projections to increase in the next few years), while the United Kingdom reported a lack of organs for 8000 patients, with the rate increasing at 8%. In response to the high demands and long waiting times, the illegal organ trade has been expanding. Currently, it is estimated that about 10% of all transplants occur illegally, with the Internet acting as a facilitator. For 2006, it was estimated that at least 4000 prisoners were executed to supply approximately 8000 kidneys and 3000 livers for foreign buyers. In 2007, 2500 kidney transplants were bought in Pakistan, with foreign recipients making up two-thirds of the purchases. As of 2007, the Voluntary Health Association of India estimates that approximately 2000 Indians sell a kidney every year. And in Canada and the United Kingdom, experts estimate that about 30 to 50 patients illegally purchased organs abroad.
The United Network for Organ Sharing defines transplant tourism as "the purchase of a transplant organ abroad that includes access to an organ while bypassing laws, rules, or processes of any or all countries involved." The term transplant tourism describes the commercialism that drives illegal organ trade, but not all medical tourism for organs is illegal. Examples include when both the donor and recipient of the organ travel to a country with adequate facilities to perform a legal surgery or a recipient travels to receive the organ of an abroad relative. Transplant tourism raises concerns because it involves the transfer of healthy organs in one direction, depleting the regions where organs are bought. This transfer typically occurs from South to North, developing to developed nations, females to males, and from people of color to whites, a trend that experts say "has exacerbated old...divisions."
The kidney is the most sought after organ in transplant tourism, with prices for the organ ranging from as little as $1300 to as much as $150,000. In fact, reports estimate that 75% of all illegal organ trading involves kidneys. The liver trade is also prominent in transplant tourism, with prices ranging from $4000 to $157,000. Though livers are regenerative and thus not fatal to remove from donors, liver donations are much less common due to an excruciating recovery period that deters donations. Other high-priced bodily organs commonly sold in the organ trade include corneas ($24,400) and unfertilized eggs ($12,400), while lower-priced bodily commodities include blood ($25–$337), skin ($10 per square inch) and bones/ligaments ($5,465). While there is a high demand, and correspondingly a very high price, for vital organs such as hearts or lungs, transplant tourism and organ trafficking of these parts is very rare due to the sophisticated nature and the state-of-the-art facilities required for such transplants.
In view of the increasing activity of the illegal organ trade and transplant tourism, the international community has issued many ordinances and declarations against the selling of organs. Examples include the 1985 denouncement of organs for commercial use by the World Medical Authority, the Council of Europe's Convention on Human Rights and Biomedicine of 1997 and its 2002 Optional Protocol Concerning Transplantation of Organs and Tissues of Human Origin, and the Declaration of Istanbul on organ trafficking and transplant tourism. The World Health Organization has played a prominent role in condemning the illegal organ trade. The WHO first declared organ trade illegal in 1987, stating that such a trade violates the Universal Declaration of Human Rights. In 1991, it approved nine guiding principles for human organ transplant at the 44th World Health Assembly, clearly stating among the guidelines that organs cannot be the subject of financial transactions. On May 22, 2004, these guidelines were slightly amended at the 57th World Health Assembly and are intended for governments. These global initiatives have served as a helpful resource for establishing medical professional codes and a legal framework for the issue, but have not provided or declared necessary sanctions to enforce their decrees.
Declaration of Istanbul
The Declaration of Istanbul on organ trafficking and transplant tourism, drafted by the international transplant community, defines transplant commercialism, organ trafficking, and transplant tourism and denounces the practices based on violations to equity, justice and human dignity. The declaration aims to invoke and promote ethical practices in organ transplantation and donation on an international level. The declaration is nonbinding, but over 100 transplant organizations support its principles, including countries such as China, Israel, the Philippines, and Pakistan, who have strengthened their laws against illegal organ trading after release of the declaration.
Impact on the poor
Data from the World Health Organization indicates that the primary group targeted by the illegal organ trade is impoverished individuals in developing nations. In a study of organ donors in India, it was found that 71% of all donors fell below the poverty line. Tales of organ theft usually characterize the victims as unemployed males between ages 20–40 who are seeking work and are taken out of the country for operations. This is seen in the case of Makbuba Aripova, whose husband left Uzbekistan for a job in Canada. Her corpse and those of family members traveling with her were found several days later with missing organs and bags of money believed to be the proceeds from an organ sale. While men feature prominently in anecdotes on the organ trade, impoverished women are also frequent victims. However most data show that women are rarely the recipients of purchased organs.
Reasons for donating
Considering the poor status of most donors, one of the primary stated reasons for organ selling is to pay off debt. Those who are poorest are frequently seen as more reliable targets for transplant tourists because they are the most in need of money. It has been argued that by providing compensation to donors, the organ trade is helping to lift some people out of poverty. However evidence of this claim is still being debated. In many cases, people who sell their organs in order to pay off debt do not manage to escape this debt and remain trapped in debt cycles. Often people do not make an informed choice to donate their kidneys to strangers, but are forced into doing so due to extreme poverty. It is therefore problematic to establish informed consent when the decision to donate is economically motivated, particularly in unregulated organ markets. The donor's social conditions are highly important in understanding the motives and outcomes of organ donation particularly in relation to economically disadvantaged organ donors. This problem of informed consent and kidney vendors being driven by poverty to sell their organs was also noted by Diane Tober in her article "Kidneys and Controversies in the Islamic Republic of Iran.
In some cases, organs are sold to other family members, either from parents to offspring, or from adult children to parents. This is more frequent in nations where waiting lists are less formal and among families that cannot afford to leave the country for transplants. The trend of younger people donating to their more aged relatives is relatively new, and has been criticized for placing greater value on kidneys from live donors.
Reports by the World Health Organization show decreased health and economic wellbeing for those who donate organs through transplant tourism. In Iran 58% of donors reported negative consequences for their health status. In Egypt, the number rose as high as 78%, and 96% of donors stated that they regretted doing so. These findings are relatively consistent across all countries; those who sell their organs on the market tend to have lower overall health. Substandard conditions at the time of transplant can also lead to transmission of diseases like hepatitis B and C and HIV. The poor health of donors is further exacerbated by depression and other mental illnesses brought on by the stress of donating and insufficient care after surgery.
Impoverished donors' economic outcomes are no better than their health outcomes. In a study of Indian donors, it was found that 96% of donors sold a kidney to pay off debts, however 75% of all donors still had this debt after a period of time. Organ brokers frequently do not pay the full amount promised to the donor. Cash that is received for the donation is often quickly spent on post-surgery care that is not provided by the buyer. In a study of Iran, the only nation that has legalized payment for organs, it was found that 66% of donors reported lower financial status. While the Iranian model does provide better compensation for donors and has subsidized the cost of immunosuppressant drugs, it has been argued that the non-negotiable price of a kidney drastically devalues the donor at the expense of the patient. Donors in all countries often report weakness after surgery that leads to decreased employment opportunities, especially for those who make a living through physical labor.
The issue of organ trade, both illegal and legal, has been and continues to be the subject of much debate from a wide range of scholars representing diverse perspectives. These debates have resulted in many different solutions addressing the high demand for organs and the rise in illicit trading, including but not limited to a free market for organs, increased legislative regulations and sanctions against illegal organ trading, and implementation of "presumed consent" laws for organ donations. These proposed solutions stem from a large field of academic perspectives, discussed below.
Criminal justice perspective
The criminal justice perspective considers the functioning of organ trade from a legal, judicial viewpoint. Though many statutes regarding organ trade exist, law officials have failed to successfully enforce these mandates. One barrier towards enforcement includes a lack of communication between medical authorities and law enforcement agencies. Often, enforcement officials' access to information regarding individuals involved in illegal organ transplants is hindered by medical regulations such as confidentiality. Without the ability to review medical records and histories to build an effective case against perpetrators, officials cannot fully enforce organ trade laws. Many critics state that in order to achieve effective prohibition of illegal organ trading, criminal justice agencies must collaborate with medical authorities to strengthen knowledge and enforcement of organ trade laws. Critics also support other criminal justice actions to meet this goal, such as prioritization of organ trafficking with local leveal and legislative bodies, multidisciplinary collaboration in cross-border offenses, and further police training in dealing with organ trafficking crimes.
The consensus of American Economic Association members is that organ trade should be legalized (70% vs. 16%).
In Journal of Economic Perspectives Nobel laureate Gary Becker and Julio Elias estimated that a $15,000 compensation would alleviate the shortage of kidney donors. The government could pay the compensation to guarantee equality.[disambiguation needed] This would save public money, as the dialysis for the patients is so expensive.
Many scholars advocate the implementation of a free market system to combat the economic shortage of available organs for transplant that helps drive illegal organ trade. This illegal status of organ trade creates a price ceiling for organs at zero dollars. This price ceiling affects supply and demand, creating a shortage of organs in the face of a growing demand. According to a report published by the Cato Institute, a US-based libertarian think tank, the elimination of the price ceiling would eliminate the shortage. However, the idea of organ "scarcity" had been opposed by Ivan Illich and other authors who argued that "scarcity" is an "artificially created need". There is not a real shortage of organs, but "excess and wasted" organs. Scarcity only exists for some groups of people—those who were denied the organs, and those who could not afford them. So what needs to be regulated, according to these authors, is organs procurement and distribution practices.
Currently, with little incentive to donate an organ approximately 6,000 people die yearly waiting for a transplant organ. It has been argued by David Holcberg that the regulation of organ trade could solve the organ shortage and create safer, fair practices for donors. Supporters of regulation argue that by implementing a regulated market system, prices for organs would actually be lower than current black market values since an increased supply drives prices down. These lowered organ prices could result in a disincentive to engage in black market organ trading, since illegal brokers would have less of a monetary gain. Additionally, the increased supply would result in lower waiting periods for transplant recipient, which would reduce hospital costs.
However, other critics state that such a market would only increase already high prices for organs, creating an imbalance: only wealthy individuals would be able to purchase these organs. They also argue that such a free market system for organ trade would encourage organ theft through murder and neglect of sick individuals for a financial gain. Advocates for the free market of organs counter these claims by saying that murder for money (e.g. cars, jewelry, etc.) already happens; sanctions against such acts exist to minimize their occurrence, and with proper regulation and law enforcement, such incidents in a legal organ trade could be minimized as well.
Medical ethics perspective
The debate on ethics and morality of organ trade remains a hot topic in today's society. Everyday, the supporting evidence is changed due to the dynamic nature of our technological advancements in medicine and our understanding of ethics itself. At the moment, although organ trade is illegal in almost all countries, it is still difficult to provide a solid conclusion in the field of business ethics without a bias based on one's basic beliefs, culture, or religion. Particularly, religion plays a major role in the topic of bodily autonomy in regards to organ trade. Bodily autonomy is defined as the "ability to make choices about how [one's] body is to be treated by others." Many religious activists and theorists say this idea of bodily autonomy treats the body as property, which goes against many religious views that the body and self are one entity. Therefore, from a religious stance selling a part of your body is analogous to selling your inner self, or soul, which is regarded as a violation of human dignity in many religious communities 
Advocates for bodily autonomy argue that the freedom to make decisions about one's body does not violate one's dignity but actually increases a person's sense of control and empowerment. By exercising their right to choose what to do with their body, they will be further empowered and effectively increase their bodily autonomy. Additionally, advocates of bodily autonomy support their arguments by citing examples of activities in today's society that pose risks analogous to organ trade. For example, the ability to endanger one's body by joining the military, acting as a surrogate mother, and/or engaging in medical experiments are all accepted in today's society fueled by financial incentives. By these standards, they argue, the right to choose whether to sell an organ should be supported.
Shortage on organs has led to the use of old and ill donors, which may lead to cancerous or weak organs being used. On the other hand, waiting for transplants also involves a high risk. There are millions of kidney patients in the world but in 2007 only 65,000 kidneys were transplanted. In the U.S. 83,000 patients wait for kidney transplants but just 16,500 of them received a kidney in 2008 and 5,000 died in waiting.
Legalization of organ trade
Legalization of human organ trading has been opposed by a variety of human rights groups like the Organs Watch, a group established by medical anthropologist Nancy Scheper-Hughes who was instrumental in exposing illegal international organ selling rings. Much like the Organs Watch, the World Health Organization seeks to protect and benefit the poverty-stricken individuals who participate in the illegal organ trade out of necessity. However, the act of selling oneself (or a portion of oneself) for monetary gain is still viewed as a lucrative opportunity. Indeed, much academic debate is leaning towards the decriminalization and regulation of organ trade as a viable solution for organ trafficking.
However, in 2010, UC Berkeley professor and Organ Watch director Nancy Scheper-Hughes already supported legal compensation for organ donations. She also says that compensations are already paid in the “don’t ask, don’t tell” sense. Behind this lies the desperation due to shortage of organ donations. Scheper-Hughes is famous for her investigations that lead to several arrests due to third-world people begin forced or fooled into organ donations.
Several solutions have been put forward to both increase the amount of legally available organs and stanch the flow of illegal trafficking around the globe. Policies of presumed consent have been successful in various countries such as Brazil, the United States, and several nations of Europe. These policies can be either opt-in or opt-out. In a nation with an opt-out policy, consent for organ donation is presumed upon death, although one can choose not to donate by submitting documentation. Research shows a 25-30% increase in the amount of available organs in opt-out countries. In nations with an opt-in policy, like the United States or France, a person may choose to donate their organs during their lifetime. In opt-in countries, families have on occasion succeeded in overturning the decision of the deceased to donate.
Presumed consent programs cut down on organ trafficking in many ways. These laws help increase the amount of available organs, decreasing the reliance of patients on the black market. At the same time, the increased amount of organs cuts the financial cost of a transplant, decreasing the need for medical tourism.
Another method that has been recommended is to enact laws that would hold doctors accountable for not reporting suspected organ trafficking. Medical anthropologist Nancy Scheper-Hughes has written extensively on the issue of doctors knowingly performing illegal operations with illicit organs. While it can be argued that expecting doctors to come forward violates doctor-patient privilege, their legal obligation to the patient, according to Scheper-Hughes, is superseded by public interest in ending alleged medical violations of human rights. If accountability measures were imposed, doctors would be liable as accomplices if they knowingly performed operations with black market organs.
Many in the United States believe that adopting a system for regulating organ trading similar to Iran's will help to decrease national the shortage of kidneys. By promoting accountability, ensuring safety in surgical practices, employing vendor registries, and providing donors with lifetime care, it has been stipulated the US could adopt similar policies. Arguments have been made that private insurance agencies would be invested in providing such care for donors, as the procedure would become relatively standard given the long waitlist for organs. Alternatively, laws could be enacted that make long-term care an intrinsic part of any donation agreement. By legalizing and incorporating organ trade into the domain of government, poverty could be eliminated and the necessity of a black market for organs would be mitigated.
- Black market
- Gurgaon kidney scandal
- Organ donation
- Organ harvesting in the People's Republic of China
- Organ donation in Israel
- Operation Bid Rig
- Fetus Farming Prohibition Act
- Organ theft in Kosovo
- Organ harvesting
- "Experts warn against organ trade". BBC News. 2007-01-08. Retrieved 2008-02-18.
- Live donors to get financial support, RASHIDA YOSUFZAI, AAP, APRIL 07, 2013
- Author A (2008). "Singapore legalises compensation payments to kidney donors". BMJ 337: a2456. doi:10.1136/bmj.a2456.
- Griffin, Anne (March 2007). "Iranian Organ Donation: Kidneys on Demand". British Medical Journal 334 (7592): 502–505. doi:10.1136/bmj.39141.493148.94. PMC 1819484. PMID 17347232.
- Hippen, Benjamin E. "Organ Sales and Moral Travails: Lessons from the Living Kidney Vendor Program in Iran". Cato Institute: Policy Analysis.
- Tober, Diane (2007). "Kidneys and Controversies in the Islamic Republic of Iran: The Case of Organ Sale.". Body and Society 13 (3): 151–170. doi:10.1177/1357034x07082257.
- The Meat Market, The Wall Street Journal, Jan. 8, 2010.
- Ghods AJ, Savaj S (November 2006). "Iranian model of paid and regulated living-unrelated kidney donation". Clin J Am Soc Nephrol 1 (6): 1136–45. doi:10.2215/CJN.00700206. PMID 17699338.
- "The Debate: Presumed Consent". Retrieved 2012-10-24.
- "Organ Trafficking Laws in Key Countries". Retrieved 2012-10-24.
- "Psst, wanna buy a kidney?". Organ transplants. The Economist Newspaper Limited 2011. November 16, 2006. Retrieved 12 June 2011.
- Schall, John A. (May 2008). "A New Outlook on Compensated Kidney Donations". RENALIFE. American Association of Kidney Patients. Retrieved 14 June 2011.
- Martinez, Edecio (July 27, 2009). "Black Market Kidneys, $160,000 a Pop". CBS News. Retrieved 12 June 2011.
- An Open Letter to President Barack Obama, Secretary of Health and Human Services Sylvia Mathews Burwell, Attorney General Eric Holder and Leaders of Congress
- Truog, Robert D. (2005). "The Ethics of Organ Donation by Living Donors". New England Journal of Medicine 353: 444–446. doi:10.1056/NEJMp058155.
- ...With Functioning Kidneys for All, munuaisensa luovuttanut päätoimittaja Virginia Postrel, The Atlantic, JUL 9 2009.
- Should the Purchase and Sale of Organs for Transplant Surgery be Permitted?, economics professor Gary S. Becker, 2006-01-01.
- Introducing Incentives in the Market for Live and Cadaveric Organ Donations, Gary S. Becker and Julio Jorge Elías, University of Chicago.
- The Dark Side Of Organ Donation, CBS News, August 12, 2003.
- The Ethics of Free-Market Kidneys, Part 1, Benjamin Radford, February 4, 2014, Center for Inquiry.
- David Matas, Esq. and Hon. David Kilgour, Esq. (31 January 2007). "Bloody Harvest: Revised Report into Allegations of Organ Harvesting of Falun Gong Practitioners in China". organharvestinvestigation.net. p. 237.
- Annika Tibell The Transplantation Society’s Policy on Interactions With China 2007
- Hemphill, Joan E. (2007). "China's Practice of Procuring Organs From Executed Prisoners: Human Rights Groups Must Narrowly Tailor Their Criticism and Endorse the Chinese Constitution to End Abuses". Pacific Rim Law & Policy Journal Association 16 (2): 431–457.
- Glaser, Sheri R. (2007). "Formula to Stop the Illegal Organ Trade: Presumed Consent Laws and Mandatory Reporting Requirements for Doctors" (PDF). Human Rights Brief.
- "New Witness Confirms Existence of Chinese Concentration Camp, Says Organs Removed from Live Victims" Epoch Times, 17 March 2006
- Organ Harvesting minghui.org
- Watts, Jonathan (9 June 2007). "China Introduces New Rules to Deter Human Organ Trade". The Lancet 369 (9577): 1917–1918. doi:10.1016/S0140-6736(07)60897-6.
- "Organ harvesting". Chinaview.wordpress.com. Retrieved 5 January 2015.
- "Organ Shortage Fuels Illicit Trade in Human Parts". Retrieved 2008-05-01.
- "India Kidney Trade". Retrieved 2008-05-01.
- "Hub For Global Organ Trade". Retrieved 2008-05-01.
- "Indian Journal of Medical Ethics: Asia’s Organ Farms". Retrieved 2008-05-01.
- Scheper-Hughes, Nancy (2008). The Last Commodity: Post-Human Ethics, Global (In)Justice, and the Traffic in Organs. Penang: Multiversity & Citizens International. ISBN 9789833302093.
- "Cabral warns: No more organs for sale in Philippines".
- Turner, Leigh (2009). "Commercial Organ Transplantation in the Philippines". Cambridge Quarterly of Healthcare Ethics 18 (2): 192–196. doi:10.1017/S0963180109090318.
- "Philippines Claims Success on Organ Trafficking". Retrieved 2012-10-24.
- Lee Mendoza Roger (2010). "Kidney black markets and legal transplants: Are they opposite sides of the same coin?". Health Policy 94 (3): 255–265. doi:10.1016/j.healthpol.2009.10.005.
- Jafar, Tazeen H. (2009). "Organ Trafficking: Global Solutions for a Global Problem". American Journal of Kidney Diseases 54 (6): 1145–1157. doi:10.1053/j.ajkd.2009.08.014.
- Ambagtsheer, F.; Weimar, W. (2011). "A Criminological Perspective: Why Prohibition of Organ Trade Is Not Effective and How the Declaration of Istanbul Can Move Forward". American Journal of Transplantation 12 (3): 571–575. doi:10.1111/j.1600-6143.2011.03864.x.
- Shimazono, Yosuke (2007). "The State of the International Organ Trade: A Provisional Picture Based on Integration of Available Information". Bulletin of the WHO 85 (12). doi:10.1590/S0042-96862007001200017.
- Fan, Jiayang (10 January 2014). "Can China Stop Organ Trafficking?". The New Yorker.
- "CHINA FACES ENORMOUS CHALLENGES IN ENDING ORGAN TRAFFICKING". The Laogai Research Foundation. 13 January 2014.
- Roger Lee Mendoza (2012). Transplant management from a vendor’s perspective. Journal of Health Management, 14, 1 (March 2012): 67-74, http://jhm.sagepub.com/content/14/1/67.abstract.
- "Organ Trading in Jordan". Retrieved 2008-05-01.
- Glaser, Sheri R. 2005. "Formula to Stop the Illegal Organ Trade: Presumed Consent Laws and Mandatory Reporting Requirements for Doctors". Human Rights Brief. Volume 12: Issue 20
- "The trade in human organs in Tamil Nadu: the anatomy of regulatory failure". Archived from the original on 2008-05-18. Retrieved 2008-05-01.
- Budiani-Saberi, D. A.; Delmonico, F. L. (2008). "Organ Trafficking and Transplant Tourism: A Commentary on the Global Realities". American Journal of Transplantation 8 (5): 925–929. doi:10.1111/j.1600-6143.2008.02200.x. PMID 18416734.
- Meyer, Silke (2006). "Trafficking in Human Organs in Europe: A Myth or an Actual Threat?". European Journal of Crime, Criminal Law & Criminal Justice 14 (2): 208–229. doi:10.1163/157181706777978739.
- Stephanie Condron (11 May 2007). "Gambler tried to sell his kidney online". The Daily Telegraph (London).
- Mozgovaya, Natasha (2009-07-26). ", but these allegations were later proven false. Prof. says she told FBI of kidney trafficking". Haaretz.
- Allain, J. (2011). "Trafficking of Persons for the Removal of Organs and the Admission of Guilt of a South African Hospital". Medical Law Review 19 (1): 117–122. doi:10.1093/medlaw/fwr001.
- "Organ trafficking case sent to Kosovo Court (SETimes.com)". 2010-12-14. Retrieved 2010-12-15.
- "An Organ-Trafficking Conviction in Kosovo".
- Leventhal, Todd. 1994. "The Child Organ Trafficking Rumor: A Modern Urban Legend." United States Information Agency Report.
- Delmonico, Francis L. (2009). "The Implications of Istanbul Declaration on organ trafficking and transplant tourism". Current Opinion in Organ Transplantation 14 (2): 116–119. doi:10.1097/MOT.0b013e32832917c9.
- Campbell, Denis; Davison, Nicola (May 27, 2012). "Illegal kidney trade booms as new organ is ‘sold every hour’". The Guardian.
- "Human organ black market exploiting poverty and hope," China Post, May 10, 2010.
- (Carney, Scott. 2011. "The Red Market." Wired 19, no. 2: 112-1. Internet and Personal Computing Abstracts.)
- Scheper-Hughes, N 2000, ‘The global traffic in human organs’, Current Anthropology, vol. 41, no. 2, pp. 191-224
- Moazam, F., R. M. Zaman, et al. (2009). Conversations with Kidney Vendors in Pakistan: An ethnographic study, Hastings Centre Report.
- Scheper-Hughes, Nancy (2007). "The Tyranny of the Gift: Sacrificial Violence in Living Donor Transplants". American Journal of Transplantation 7 (3): 507–511. doi:10.1111/j.1600-6143.2006.01679.x.
- Territo, Leonard (2011). The International Trafficking of Human Organs: A Multidisciplinary Perspective. Hoboken: CRC Press. ISBN 9781439867907.
- Do Economists Reach a Conclusion on Organ Liberalization?, Jon Diesel, Econ Journal Watch, Volume 7, Number 3, September 2010, pp 320-336.
- The Policy Views of American Economic Association Members: The Results of a New Survey, Robert Whaples, Econ Journal Watch, Volume 6, Number 3, September 2009, pp 337-348.
- "Price Ceilings". Retrieved 2008-05-01.
- Scheper-Hughes, N. (2002). "The Ends of the Body: Commodity Fetishism and the Global Traffic in Organs". SAIS Review 22 (1): 61–80. doi:10.1353/sais.2002.0022.
- "To Save Lives, Legalize Trade in Organs". Retrieved 2008-05-01.
- Stempsey, William E. (2000). "Organ Markets and Human Dignity: On Selling Your Body and Soul". Christian Bioethics: Non-Ecumenical Studies In Medical Morality 6 (2): 195–204. doi:10.1076/1380-3603(200008)6:2;1-7;FT195.
- Greenberg, Orfa (July 2013). "The Global Organ trade". Cambridge Quarterly of Healthcare Ethics 22 (3). pp. 238–245. doi:10.1017/s0963180113000042. ISSN 0963-1801.
- Nullis-Kapp, C. (2004). Organ Trafficking and Transplantation Pose New Challenges 82 (9th ed.). World Health Organization.
- Transplantation in the USA: The Shortage of Available Organs and Public Health Policy, Jonathan A. Winston, M.D., Program Chair, April 19, 2010, Kidney & Urology Foundation of America.